Overview
Tranexamic Acid in Pediatric Scoliosis Surgery
Status:
Recruiting
Recruiting
Trial end date:
2025-09-01
2025-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to investigate whether intraoperative administration of tranexamic acid based on ROTEMĀ® (Rotational Thromboelastometry), in pediatric patients undergoing scoliosis surgery, results in a difference in intraoperative blood loss when compared to the prophylactic administration of tranexamic acid.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Seoul National University HospitalTreatments:
Tranexamic Acid
Criteria
Inclusion Criteria:- Children undergoing scoliosis surgery under the age of 18
Exclusion Criteria:
- Patients with coagulation disorders
- Patients at an increased risk of thrombosis
- Patients with a history of epilepsy or brain surgery
- Patients with a previous allergic reaction or anaphylaxis history to tranexamic acid
- Severe liver or kidney impairment
- Other cases deemed inappropriate by the researcher